Home > Newsletters > The QMN Weekly Bulletin > FDA Warns Epimed International for Supplier Control, Procedural Issues
The QMN Weekly Bulletin
Oct. 12, 2012 | Vol. 4 No. 41
FDA Warns Epimed International for Supplier Control, Procedural Issues
Lax process and quality control of supplied components helped land Irving, Texas-based Epimed International an FDA warning letter. Following a May 1 to 17 inspection of the company’s Johnstown, N.Y., plant, the FDA recounted flaws in the company’s supplier quality process, including a failure to establish and maintain procedures for accepting incoming products.
Devices & Diagnostics Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.